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adrenalectomySummary Background: We previously reported our initial experience with laparoendoscopic
single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-port de-
vice and conventional straight laparoscopic instruments.
Methods: Between December 2010 and February 2012, LESS retroperitoneal partial adrenalec-
tomies were performed in 11 patients. Six patients had aldosterone-producing adenomas
(APAs) and five patients had nonfunctioning tumors. A single-port access was created with
an Alexis wound retractor (Applied Medical, Rancho Santa Margarita, CA, USA) through an inci-
sion of 2e3 cm beneath the tip of the 12th rib. All procedures were performed with straight
laparoscopic instruments.
Results: All LESS procedureswere successfully completedwithout conversion to traditional lapa-
roscopic conversion. The tumors ranged from 1 cm to 4.7 cm (mean, 2.3 cm). The operative time
was 71e257minutes (mean, 121minutes).Most patients (nZ8) hadminimal blood loss; theother
three patients had a blood loss of 150mL, 100mL, and 100mL. Themean hospital stay was 3 days
(range, 1e6 days). Therewere no perioperative or postoperative complications. Pathological ex-
aminations revealed negative surgical margins in all specimens. All patients with Conn’s syn-
drome had an improvement in blood pressure and normalization of plasma renin activity and
serum aldosterone levels; all patients were free of potassium supplementation.
Conclusion: Our results clearly demonstrate that LESS retroperitoneal partial adrenalectomy
can be performed safely and effectively using a custom-made single-access platform and stan-
dard laparoscopic instruments.
Copyright ª 2014, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Two decades ago, laparoscopic access to the adrenal gland
was described.1 Since then, it has replaced open surgery
and become the standard procedure for adrenal surgery
because of its high success rate, minimal morbidity, and
rapid convalescence. In the past few years, advances in
surgical instruments and/or techniques have increased the
enthusiasm and interest in more minimally invasive sur-
gery.2 Among these techniques, laparoendoscopic single-
site surgery (LESS)dcharacterized by performing laparo-
scopic procedures through a single skin incisiondhas
gradually gained popularity in recent years. Compared to
conventional laparoscopic surgery, LESS has the advantage
of a better cosmetic outcome3 and early convalescence.4
To date, LESS has been successfully applied in various op-
erations,5,6 and it was recently demonstrated as a feasible
technique in total adrenalectomy.7e9
Partial adrenalectomy (i.e., adrenal-sparing surgery)
was initially proposed with the intention to preserve the
maximal postoperative adrenocortical function and to
avoid steroid dependence in select patients (e.g., patients
with a hereditary form of pheochromocytoma or a solitary
adrenal gland).10,11 Patients who undergo unilateral total
adrenalectomy may not respond normally to stressful situ-
ations, even in patients with a normal contralateral adrenal
gland.12 For this reason, several surgical groups also
perform partial adrenalectomy in patients with
aldosterone-producing adenomas (APAs) or small adrenal
tumors.12e21 A recent literature review covering the past 2
decades reveals an increasing trend worldwide toward
partial adrenalectomy. Partial adrenalectomy can achieve
a similar surgical outcome and perioperative complications
as total adrenalectomy in various pathological conditions.13These data encourage surgeons to develop and refine
techniques for partial adrenalectomy, which is potentially
more challenging than total adrenalectomy.
In the past, partial adrenalectomy has been successfully
performed in several surgical platforms, including
conventional laparoscopy,12 needlescopy,14 and robotic-
assisted laparoscopy.22,23 Yuge et al15 more recently re-
ported the first case of LESS transperitoneal partial adre-
nalectomy. By using a custom-made single-access platform
and standard laparoscopic instruments, we also completed
11 LESS retroperitoneal partial adrenalectomy procedures.
In this paper, we report our series to evaluate the feasi-
bility of this procedure.
2. Materials and methods
Between December 2010 and February 2012, 11 adult pa-
tients with benign adrenal tumors underwent LESS retro-
peritoneal partial adrenalectomy at our institute. All
operations were performed by a single surgeon (YCT). The
diagnoses of the 11 patients were Conn’s syndrome (nZ 6)
and nonfunctioning adrenal tumors (nZ 5). Table 1 lists the
patients’ data.
After a full description and explanation of the proce-
dure, all patients signed an informed consent form. The
patients’ data, operative time, estimated blood loss, peri-
operative and postoperative complications, and outcome
were prospectively collected.
2.1. Operative techniques
Under general anesthesia, the patient was placed in a
prone jackknife position. The operation started with the
placement of a custom-made single port and the creation of
Table 1 Patients’ characteristics and surgical outcomes.
Patient Age
(y)
Sex Site Tumor
size
(cm)
Diagnosis Operation
time (min)
Blood
loss
(mL)
Hospital
stay (d)
Clinical
outcome
Postoperative
laboratory test
results
Follow-up
period
(mo)
1 52 Female R, medial
limb
1.4 Conn’s syndrome 105 0 2 Resolution
of HTN
Normal
aldosterone/
renin ratio and
serum K level
6
2 71 Female R, medial
limb
3.4 Nonfunctioning
tumor
136 150 6 N.A. 27
3 66 Male R, medial
limb
1 Conn’s syndrome 105 0 5 Resolution
of HTN
Normal
aldosterone/
renin ratio and
serum K level
3
4 54 Female R, medial
limb
3.2 Conn’s syndrome 84 0 4 Resolution
of HTN
Normal
aldosterone/
renin ratio and
serum K level
3
5 47 Male L, lateral
limb
1.7 Nonfunctioning
tumor
71 0 1 N.A 3
6 56 Female L, medial
limb
2.5 Conn’s syndrome 80 0 1 Improvement
of HTN
Normal
aldosterone/
renin ratio and
serum K level
5
7 52 Female L, medial
limb
4.7 Nonfunctioning
tumor
257 100 2 N.A 3
8 57 Male L, medial
limb
3 Nonfunctioning
tumor
132 100 6 N.A 3
9 78 Female L, medial
limb
1.3 Conn’s syndrome 136 0 3 Improvement
of HTN
Normal
aldosterone/
renin ratio and
serum K level
19
10 45 Female R, lateral
limb
1.7 Conn’s syndrome 95 0 2 Resolution
of HTN
Normal
aldosterone/
renin ratio and
serum K level
22
11 66 Male R, lateral
limb
1.5 Nonfunctioning
tumor
132 0 2 N.A. 21
HTN Z hypertension; K Z potassium; L Z left; N.A. Z not applicable; R Z right.
8 C.-H. Ho et al.the pneumoretroperitoneum, as described previously.9 A
skin incision of 2e3 cm was formed just beneath the tip of
the 12th rib. The subcutaneous tissues and fascia were
dissected sharply. With blunt finger dissection, a retroper-
itoneal space was created for the placement of the single
port. An Alexis wound retractor (Xsmall; Applied Medical,
Rancho Santa Margarita, CA, USA) was placed in position
through the incision with the bottom ring inside the
abdomen. Double-layered sterile surgical gloves were then
snapped onto the external ring, and the upper half of the
glove parts (including the five fingers) were ligated and
truncated.
A 5-mm laparoscopic standard trocar was inserted
through the gloves and secured by a purse-string suture
around the trocar. The capnoretroperitoneum was created
by a carbon dioxide pressure of 20e30 mmHg.24e26 After
establishing the pneumoretroperitoneum, a rigid 5-mm 30
laparoscope was inserted for inspecting the retroperitoneal
cavity. Two additional 5-mm operating trocars wereinserted using the same procedure. Standard straight
laparoscopic instruments were used for subsequent
manipulation.
After creating the retroperitoneal space by blunt
dissection, Gerota’s fascia and the adrenal gland were then
well exposed. A careful dissection was performed to iden-
tify the tumor, based on preoperative image studies. The
central adrenal vein remained intact, unless the tumor was
close to a venous origin in which case the vein was
controlled by Hem-o-lock clips (Weck, Research Triangle
Park, NC, USA). When the tumor was exposed adequately,
the tissue surrounding the normal part of the adrenal gland
was dissected as minimally as possible to preserve the
blood supply to the remaining tissue. Dissection was per-
formed by a 5-mm LigaSure V Sealer/Divider (Covidien,
Valleylab, Boulder, CO) to free the tumor from the
remaining adrenal tissue. The operative field was inspected
for hemostasis. In patients with active bleeding along the
surgical margin (n Z 8), fibrin glue (Floseal; Baxter
LESS retroperitoneal partial adrenalectomy 9Healthcare, Irvine, CA, USA) was used for adequate he-
mostasis. The resected adrenal tumor and its surrounding
tissue were placed in a retrieval bag that was inserted
directly after the detachment of the snapped double sur-
gical gloves, and removed through the Alexis wound
retractor.2.2. Postoperative follow-up examination
The patients were regularly followed in our clinic with the
first endocrine follow-up at 3 months, and then every 6
months for computed tomography imaging. The follow-up
period ranged 3e27 months with a median follow up of 5
months. Follow-up computed tomography imaging detected
tumor recurrence.Figure 2 The green line indicates the margin of the adrenal
gland and the broken line indicates the resection margin after
partial adrenalectomy.3. Results
Table 1 summarizes the perioperative data. No patient
required conversion to an open or conventional retro-
peritoneoscopic approach. All adrenalectomies were suc-
cessfully completed with two conventional laparoscopic
instruments. The total operation time ranged 71e257 mi-
nutes (mean, 121 minutes). Bleeding was minimal in most
patients (nZ 8). Only three patients (Cases 2, 7, and 8) had
a greater amount of blood loss, amounting to 150 mL,
100 mL, and 100 mL, respectively; none of these three
patients required a blood transfusion. The fluctuation in
blood pressure was easily controlled during all 11 pro-
cedures. The total drug dose for pain control post-
operatively was minimal (mean meperidine use, 0.61 mg/kg
per patient; mean acetaminophen use, 66.7 mg/kg per
patient). The mean 2-hour, 24-hour, and 1-week post-
operative visual analog scale (VAS) pain scores were 3.8,
1.5, and 0, respectively, at rest; and 5.5, 4.2, and 0.7,
respectively, with activity. None of the 11 patients required
pain medication after more than 12 hours postoperatively.Figure 1 A right-sided adrenal tumor in a patient with an
aldosterone-producing adenoma (prior to tumor resection).
The green line indicates the margin of the adrenal gland and
the broken line delineates the margin of the adrenal tumor.Pathological examination revealed that all adrenal tu-
mors were removed en bloc (Figs. 1 and 2). No peri- or
postoperative complications occurred. All patients started
oral intake and ambulation on the day of the operation. The
early cosmetic results were excellent. The hospital stay
was 1e6 days (mean, 3 days). None of the patients expe-
rienced tumor recurrence during the follow-up period.
Fig. 3 shows a representative pre- and postoperative
computed tomography of a single patient.
4. Discussion
Total adrenalectomy has historically been the standard
procedure for treating all adrenal tumors, regardless of
their size and site.13 It is effective for radically removing a
causative tumor; however, it may cause the adverse effects
of adrenal insufficiency and the need for steroid replace-
ment in some scenarios such as solitary adrenal glands,
bilateral adrenal involvement, or hereditary adrenal tu-
mors. For example, one study demonstrated that 33% of
patients who underwent bilateral adrenalectomy for mul-
tiple endocrine neoplasia type 2 had significant medical
problems related to the lack of endogenous steroid pro-
duction and required hospital admission.27,28 Partial adre-
nalectomy was initially performed in patients with
hereditary pheochromocytomas to avoid the aforemen-
tioned complications and steroid dependence. A series by
Yip et al21 included 26 patients who underwent cortical-
sparing surgery for hereditary pheochromocytomas: 17
(65%) patients remained steroid-independent for a median
follow-up period of 71 months and only three (10%) patients
had a recurrence. In another study of 36 partial adrenal-
ectomies for pheochromocytomas in 26 patients with von
Hippel-Lindau, only three (11%) patients required steroid
supplementation during the long-term follow up. Radiologic
imaging detected recurrence in only three (11%) patients,
and all were clinically asymptomatic.29 These data strongly
indicate that partial adrenalectomy should be the treat-
ment of choice in patients with potential postoperative
adrenal insufficiency and steroid dependence.
Figure 3 Pre- and postoperative (at 19 months) computed tomography images of a single patient. The postoperative image
confirmed the successful removal of the adrenal tumor and showed no tumor recurrence.
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with a normal contralateral adrenal gland is more contro-
versial. Ishidoya et al30 prospectively randomized 92 pa-
tients with APA by laparoscopic total adrenalectomy
(n Z 63) or by partial adrenalectomy (n Z 29), and
compared the surgical outcomes of the two groups. Both
groups postoperatively had significant improvement in
blood pressure, plasma renin activity, and serum aldoste-
rone levels. Only two of the 29 patients in the partial
adrenalectomy group still experienced hypertension with
high plasma aldosterone. Of the 63 extirpated specimens,
17 (27.0%) adrenal glands demonstrated multiple space-
occupying lesions in addition to the main APA. Ishidoya
et al30 therefore concluded that primary hyper-
aldosteronism is highly associated with multiple adrenal
space-occupying lesions and suggested total adrenalectomy
should be performed in patients with unilateral APA. How-
ever, the APA multifocality in these patients may not
compromise the clinical outcome after partial adrenalec-
tomy. A recent literature review, which included 174 pa-
tients with APA undergoing partial adrenalectomy, reveals
that no patient clinically experienced a recurrence.13 Fu
et al31 more recently reported their long-term results of a
prospective randomized trial comparing retroperitoneo-
scopic partial adrenalectomy (n Z 104) and total adrenal-
ectomy (n Z 108) for APA. After a mean follow-up of 96
months, all patients in each group had an improvement in
hypertension. Thirty-two (29.6%) patients in the total
adrenalectomy group and 29 (27.9%) patients in the partial
adrenalectomy group could decrease their dose of antihy-
pertensive medications or use fewer antihypertensive
medications. All patients’ plasma renin activity and aldo-
sterone level returned to normal after surgery. No patient
required potassium supplements postoperatively. Fu et al31
therefore concluded that the therapeutic results of partial
adrenalectomy and total adrenalectomy are comparable in
patients with primary hyperaldosteronism due to APA. By
contrast, Nakada et al12 found that angiotensin II induces
aldosterone release by activating tumor uninvolved cortical
cells, and found that adrenal-sparing surgery may yield
better functional results, compared to unilateral total
adrenalectomy. Furthermore, APA is particularly amenableto adrenal-sparing procedures because the tumor is often
small, solitary, and peripherally located.13,32 All previously
mentioned evidence supports partial adrenalectomy as the
first line treatment in APA.
Partial adrenalectomy is a more challenging technique
than total adrenalectomy. Similar to other organ-sparing
procedures, the keys to success include visualizing the
tumor; inspecting for additional masses, negative margins,
hemostasis; andminimizing damage to the remaining adrenal
tissue. Some authors suggest fully exploring the whole gland
prior to dissecting the adrenal mass.16,20 In our practice, we
limited the range of exploration to maintain the blood supply
of the remaining tissue whenever it is enough to allow a
radical tumor removal. This is because preserving the adrenal
gland may have a better remnant function.32,33 We believe
that awhole adrenal gland exploration is only necessary in the
following conditions: (1) a whole exploration is required for
centrally located tumors to evaluate the margin status and to
ensure a radical tumor resection; and (2) in tumors that are
adjacent to the adrenal vein, we also expose the whole gland
to evaluate whether adrenal vein ligation is necessary. How-
ever, in tumors located peripherally or away from the adrenal
vein, we intended to minimize the dissection to preserve the
blood supply and/or venous drainage.
Another major issue in partial adrenalectomy is the risk
of intraoperative or postoperative bleeding.15,31 A satis-
factory hemostasis reportedly can be achieved simply by
using electrocautery and an ultrasonic scalpel while
resecting adrenal tumors from the normal adrenal paren-
chyma.14 Other authors have added fibrin glue for hemo-
stasis.15,16 In our experience, we routinely used 5-mm
LigaSure V Sealer/Divider (Covidien) to resect the tumors.
The pressure of the pneumoperitoneum could decrease
intraoperative bleeding. To prevent further bleeding, we
also applied fibrin glue in most of our patients (nZ 8). With
this method, most patients in our series had minimal
hemorrhaging. Only three patients had a greater blood loss
(150 mL, 100 mL, and 100 mL in Cases 2, 7, and 8,
respectively), which was because of the relatively larger
tumor size (3.4 cm, 4.7 cm, and 3 cm, respectively). The
amount blood loss in our series was generally acceptable
and comparable to those reported in previous
LESS retroperitoneal partial adrenalectomy 11series.7,8,16,17,20 Based on the results of our series and
previous studies, bleeding in partial adrenalectomy can be
well controlled by adequate thermocoagulation with or
without using fibrin glue, and it should not be a reason to
preclude this procedure.
Partial adrenalectomy has been successfully performed
by various approaches. In the past, it was performed through
an open incision. Since the 1990s, it has been broadly per-
formed through conventional laparoscopy.10,12,16,18,20,30e32
The results of the more than 300 cases in the literature
have proven that conventional laparoscopy is an effective
approach for partial adrenalectomy. A team from the Na-
tional Cancer Institute of the U.S. National Institutes of
Health (Bethesda, MD, USA)more recently demonstrated the
feasibility of robotic-assisted laparoscopic partial adrenal-
ectomy.22,23 The choice among the different techniquesmay
depend on instrument availability, a surgeon’s preferences,
a patient’s condition, the tumor characteristics (e.g., pa-
thology, size, location), and the cost.
Our LESS surgery has several advantages, compared to
the conventional technique or the robotic-assisted laparo-
scopic multiport technique. First, the single-port access has
a better cosmetic result. Second, all instruments used in
our technique, including the custom-made single-port de-
vice and straight laparoscopic instruments, are broadly
available at institutes equipped with conventional lapa-
roscopy. Third, the cost of our procedure is the same to
conventional laparoscopic surgery.
Despite all of these advantages, our LESS partial adre-
nalectomy procedure does require an advanced technique.
The major challenges of our technique are the clashing of
instruments and the lack of triangulation. More experience
and practice are required to overcome these difficulties.
In 2010, Yuge et al15 reported the first case of LESS
partial adrenalectomy; they successfully performed LESS
partial adrenalectomy for a left adrenal tumor as the first
stage in the management of a case of bilateral APA. The
tumor was successfully removed en bloc with an operative
time of 123 minutes and with minimal blood loss. Between
December 2010 and February 2012, we also performed LESS
partial adrenalectomies successfully in 11 patients. To our
knowledge, this is the first series of LESS partial adrenal-
ectomy. Our method was in several aspects somewhat
different from that of Yuge et al.15 First, we favor retro-
peritoneoscopy to approach the adrenal gland because it
has a shorter distance between the skin incision and the
adrenal gland, and liver/spleen retraction is unnecessary in
most patients.9 Second, we used a custom-made single-port
device and straight laparoscopic instruments, which are
more broadly available and cost less than specialized
commercial devices and instruments for LESS.
Our data clearly demonstrate that LESS partial adre-
nalectomy can be safely and effectively performed with a
custom-made single-port device and conventional straight
laparoscopic instruments.References
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